Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Clinical Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid vs Tricuspid Aortic Valves Using Self-Expanding Valves: A Meta-Analysis

Presenter: Enhua Wang

June 09, 2022

Presentation TVT 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presenter: Yasser Radwan

June 09, 2022

Presentation TVT 2022

Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valves

Presenter: Sarah Yousef

June 09, 2022

Presentation TVT 2022

Clinical outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid vs Tricuspid Aortic valves Using Balloon-Expandable valves: A Meta-Analysis

Presenter: Enhua Wang

June 09, 2022

Presentation TVT 2022

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Presenter: Philipp Blanke

June 08, 2022

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

Todd Neale

July 23, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

News Conference News TVT 2020

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Shelley Wood

June 24, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Presentation TVT 2019

Treating AR With Current Transcatheter Valve Platforms

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Case: J-Valve for Pure Aortic Regurgitation

Presenter: Jian Ye

June 13, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Presenter: Philipp Blanke

June 13, 2019

Advertisement

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Clinical Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid vs Tricuspid Aortic Valves Using Self-Expanding Valves: A Meta-Analysis

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valves

Clinical outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid vs Tricuspid Aortic valves Using Balloon-Expandable valves: A Meta-Analysis

CT Planning for Challenging TAVR Indications: Bicuspid, Preventing Coronary Obstruction, Valve-in-Valve

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Better for Bicuspids and Dry Leaflet Technology

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Case: JenaValve for Pure Aortic Regurgitation

Latest Clinical Data in Bicuspid Disease

Treating AR With Current Transcatheter Valve Platforms

Case: J-Valve for Pure Aortic Regurgitation

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

CT Assessment for Bicuspid Valve TAVR. Annular or Supra-Annular Sizing? Coronary Access? TAVR Repeatability?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content